> I suspect the opposite. The Scientific American estimates the cost of rbinging a new drug to market is 2.5B and that number has doubled over the past 10 years[1].
So?
> We need to find a way to allow tighter feedback loops, better data flow and less regulation without purpose.
Everybody is all for that. Obviously, the question of what is "without purpose" may depend on whom you ask.
> That would, of course, require elected officials to be qualified in various disciplines, act in the public's best interest and not accept money from lobbyists.
You can't expect politicians to be qualified as everything, but you should expect their cabinets to have a number of specialists.
So?
> We need to find a way to allow tighter feedback loops, better data flow and less regulation without purpose.
Everybody is all for that. Obviously, the question of what is "without purpose" may depend on whom you ask.
> That would, of course, require elected officials to be qualified in various disciplines, act in the public's best interest and not accept money from lobbyists.
You can't expect politicians to be qualified as everything, but you should expect their cabinets to have a number of specialists.